Aspen is now also considering the possibility of an initial public offering next year in an effort to bring its cell therapy ...

Roche RHHBY announced that it will advance pipeline candidate prasinezumab into phase III development for early-stage Parkinson’s disease. Roche has a licensing agreement with Prothena PRTA for ...

The January meeting is intended to discuss the clinical trial design, patient population, and a potential approval route for ...

Annovis Bio shares were 43% higher, at $3.33, after the company reported positive results from a Phase 3 trial for buntanetap. The late-stage clinical drug-platform company on Monday said the new data ...

A simple skin swab based on the powers of 'super smellers' could detect devastating Parkinson's disease up to seven years before symptoms appear. Parkinson's is an incurable neurological condition ...

A new study shows how failing mitochondria and rising oxidative stress may set off key steps in Parkinson’s disease.

For decades, scientists have known that mitochondria, which produce energy inside our cells, malfunction in Parkinson's disease. But a critical question remained: do the failing mitochondria cause ...